glp 1 neuroprotection GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight Visual representation of the beneficial

High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat

It has been shown to promote healthy cholesterol levels by supporting LDL receptor activity and helping regulate PCSK9mechanisms that play a central role in how the body clears and manages circulating lipids

As of June 1, 2026, there are 3,848 lawsuits pending in the federal multidistrict litigation (MDL) for general GLP-1 drug injuries and 146 pending lawsuits in the GLP-1 vision loss (NAION) MDL

Brandon Colby, MD, Founder of Sequencing and author of Outsmart Your Genes